← FDA DRUG APPROVALS

FDA NDA · NDA021466

VFEND

Sponsor: PFIZER

APPLICATION
NDA021466
TYPE
NDA
ORIGINAL APPROVAL
2003-11-14
LATEST ACTION
2003-11-14
ROUTE
Iv (Infusion), Oral
DOSAGE FORM
Injectable, Tablet
MARKETING STATUS
Prescription

Products

VFENDPrescription
VORICONAZOLE 200MG/VIAL · Injectable · Iv (Infusion)
VFENDPrescription
VORICONAZOLE 50MG · Tablet · Oral
VFENDPrescription
VORICONAZOLE 200MG · Tablet · Oral

Approval history

2003-11-14Type 6 - New Indication (no longer used) · Original · standard — Review ↗AP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industry →GMP discipline →FDA drug shortages →FDA enforcement & recalls →

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →